Use of Tregs as a Cell-Based Therapy via CD39 for Benign Prostate Hyperplasia With Inflammation

Journal of Cellular and Molecular Medicine - United Kingdom
doi 10.1111/jcmm.15137
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Prostate Artery Embolization (PAE) for Benign Prostatic Hyperplasia (BPH)

BJU International
Urology
2014English

Benign Prostatic Hyperplasia and Intraprostatic Inflammation Are Associated With Liver Inflammation: It's Time for Prevention

Andrology
EndocrinologyReproductive MedicineUrologyMetabolismDiabetes
2018English

Rezum Water Vapour Therapy for Benign Prostatic Hyperplasia

Trends in Urology & Men's Health
2019English

Cell Proliferation and Epithelia Profile in Prostate Cancer and Benign Prostatic Hyperplasia

The Open Cancer Journal
2014English

Intravesical Residual Urine of Patients With Benign Prostate Hyperplasia, Sonography Accuracy

Pakistan Journal of Biological Sciences
AgronomyCrop Science
2012English

A Population-Based Nested Case-Control Study in Taiwan: Use of 5 -Reductase Inhibitors Did Not Decrease Prostate Cancer Risk in Patients With Benign Prostate Hyperplasia

Oncologist
Cancer ResearchMedicineOncology
2012English

Metformin Reduces Prostate Cancer Risk Among Men With Benign Prostatic Hyperplasia: A Nationwide Population‐based Cohort Study

Cancer Medicine
Cancer ResearchNuclear MedicineRadiologyImagingOncology
2019English

Transforming Growth Factor Β-Receptor II Protein Expression in Benign Prostatic Hyperplasia Is Associated With Prostate Volume and Inflammation

BJU International
Urology
2010English

Antioxidant Effects of Lycopene in African American Men With Prostate Cancer or Benign Prostate Hyperplasia: A Randomized, Controlled Trial

Cancer Prevention Research
MedicineCancer ResearchOncology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy